17th December 2021, Goch, Germany: DFE Pharma announces today that its Chief Financial Officer Libor Matyasek is stepping down for personal reasons as per February 2022. Matyasek took up his role in July 2020.
DFE Pharma has appointed Clemens Groot Koerkamp as Matyasek’s successor. Groot Koerkamp brings extensive experience in international finance with companies like Hagemeyer and FrieslandCampina. In his last position he was CFO of the Bakker Group, an entrepreneurial family owned company in the distribution and transportation of food products in Europe. Clemens holds master degrees in Business Economics (University of Tilburg, the Netherlands) and Treasury management (Vrije University Amsterdam, the Netherlands). Furthermore, he holds an MBA from Purdue University in the US.
“Over the last 1,5 years Libor has played a significant role in building DFE Pharma’s financial position and setting the business on a strong pathway for the future,” Chief Executive Officer Bas van Driel said. “I would like to thank him for all his efforts and wish him the best for the future.”